EMBECTA CORP

EMBC · NASDAQ

更新於 2026-10-15 10:31:47

$6.18-0.32%
今日最高
$6.25
今日最低
$6.11
EMBECTA CORP(EMBC)股價與市場數據
搜索空狀態插圖
...

K線圖趨勢,實際資料以交易頁為準

關鍵數據

昨天開盤價
$6.19
昨天收盤價
$6.18
成交量
651.46K
市值
$350.15M
市盈率(P/E)
4.00X
每股收益(EPS)
$1.47

昨天價格區間

$6.11$6.25

52週價格區間

$2.77$14.91

公司概況

板塊
HEALTHCARE
行業
Health Care
子行業
MEDICAL INSTRUMENTS & SUPPLIES
總部
300 KIMBALL DRIVE, PARSIPPANY, NJ, UNITED STATES, 07054
國家
US
上市日期
2022-03-21
財年截止
September
流通股數
59.33M
CIK
0001872789
官方網址
www.embecta.com

Embecta Corp (EMBC) is a leading medical technology company specializing in innovative insulin delivery systems aimed at enhancing diabetes management. Born from a spin-off of Becton, Dickinson and Company, Embecta provides a comprehensive portfolio of advanced products, including cutting-edge insulin pens and syringes tailored to improve patient outcomes. With a robust focus on operational excellence and customer satisfaction, Embecta is well-positioned to capitalize on growth opportunities in the rapidly expanding diabetes care market, strengthening its leadership in this vital sector.

財務指標

營業收入

2026-06-30

$271.7M

2026-03-31

$221.8M

2025-12-31

$261.2M

2025-09-30

$264M

營業支出

2026-06-30

$104.6M

2026-03-31

$82.3M

2025-12-31

$78.5M

2025-09-30

$91.6M

淨利潤

2026-06-30

$21.1M

2026-03-31

-$4.1M

2025-12-31

$44.1M

2025-09-30

$26.4M

淨利潤率

2026-06-30

7.76%

2026-03-31

-1.84%

2025-12-31

16.88%

2025-09-30

10%

每股收益

2026-06-30

$0.56

2026-03-31

$0.27

2025-12-31

$0.71

2025-09-30

$0.50

息稅折舊攤銷前利潤

2026-06-30

$64.7M

2026-03-31

$44.9M

2025-12-31

$95.9M

2025-09-30

$60.4M

有效稅率

2026-06-30

23.55%

2026-03-31

143.15%

2025-12-31

25.12%

2025-09-30

8.96%

常見問題

風險提示

股價可能大幅波動,短時間內可能出現顯著漲跌。 數位資產與衍生性商品交易可能涉及槓桿、流動性等額外風險。 本頁內容僅供參考,不構成任何投資建議。 產品可用性與訪問可能因地區及適用法規而異。